Multicenter, comparative study of cycle control, efficacy and tolerability of two low-dose oral contraceptives containing 20 μg ethinylestradiol/100 μg levonorgestrel and 20 μg ethinylestradiol/500 μg norethisterone

Contraception

Volumn 64, Issue 1, 2001, Pages 3-10

  Endrikat, J ^a   Hite, R ^a   Bannemerschult, R ^a   Gerlinger, C ^a   Schmidt, W ^a  

^a BAYER PHARMA AG   (Germany)

Author keywords

Cycle control; Ethinylestradiol; Levonorgestrel; Norethisterone; Oral contraceptives

Indexed keywords

ETHINYLESTRADIOL; LEVONORGESTREL; NORETHISTERONE;

ACNE; ADULT; AMENORRHEA; ARTICLE; BLOOD PRESSURE; BODY WEIGHT; BREAKTHROUGH BLEEDING; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DRUG EFFICACY; DRUG TOLERABILITY; EDEMA; FEMALE; HEADACHE; HUMAN; LIBIDO; MENSTRUAL CYCLE; MULTICENTER STUDY; NAUSEA AND VOMITING; NERVOUSNESS; NORMAL HUMAN; ORAL CONTRACEPTION; PHASE 3 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; SPOTTING; STATISTICAL ANALYSIS; TREATMENT OUTCOME; VARICOSIS; VERTIGO;

ADOLESCENT; ADULT; CONTRACEPTIVES, ORAL, COMBINED; CONTRACEPTIVES, ORAL, SYNTHETIC; ETHINYL ESTRADIOL; FEMALE; HUMANS; LEVONORGESTREL; MENSTRUAL CYCLE; NORETHINDRONE; TREATMENT OUTCOME;

EID: 0034850276     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0010-7824(01)00221-9     Document Type: Article

References (12)

1. A three-year clinical investigation into efficacy, cycle control and tolerability of a new low-dose monophasic oral contraceptive containing gestodene
2. German trial of an oral contraceptive containing 0.150 mg desogestrel plus 0.020 mg ethinylestradiol
3. A review of 'once a month' combined injectable contraceptives
4. Clinical experience with a monophasic oral contraceptive containing 150 μg levonorgestrel and 30 μg ethinylestradiol: Efficacy, tolerance and metabolic interactions
5. A multicenter, uncontrolled clinical investigation of the contraceptive efficacy, cycle control, and safety of a new low-dose oral contraceptive containing 20 μg ethinyl estradiol and 100 μg levonorgestrel over six treatment cycles
6. Large observational trial of a new low-dose oral contraceptive containing 20 μg ethinylestradiol and 100 μg levonorgestrel (Miranova®) in Germany
7. Use and misuse of oral contraceptives: Risk indications for poor pill-taking and discontinuation
8. Oral contraceptives and cycle control: A critical review of the literature
9. Efficacy and safety of a low-dose monophasic combination oral contraceptive containing 100 μg levonorgestrel and 20 μg ethinyl estradiol (Alesse®)
10. A multicenter randomized comparison of cycle control, and laboratory findings with oral contraceptive agents containing 100 μg levonorgestrel with 20 μg ethinyl estradiol or triphasic norethindrone with ethinyl estradiol
11. Inhibition of ovulation by an oral contraceptive containing 100 μg levonorgestrel in combination with 20 μg ethinylestradiol
12. Ultrasound evaluation of ovarian activity under oral contraceptives